Single Anastomosis Sleeve Jejunal (SAS-J) Bypass
1 other identifier
interventional
200
1 country
1
Brief Summary
The purpose of this study is to determine the efficacy of single anastomoses sleeve jejunal bypass as a treatment for morbid obesity
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Nov 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 10, 2016
CompletedFirst Posted
Study publicly available on registry
August 17, 2016
CompletedStudy Start
First participant enrolled
November 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2017
CompletedMarch 11, 2022
February 1, 2022
5 months
August 10, 2016
February 25, 2022
Conditions
Outcome Measures
Primary Outcomes (3)
operative time
the operative time from skin incision to skin closure
the 1st 24 hours
intraoperative complications
intraoperative complications like bleeding, other organs injuries
the 1st 24 hours
the postoperative weight loss
the percentage of weight loss from total excess body weight
12 month
Secondary Outcomes (1)
effect on metabolic syndrome if present
12 months
Other Outcomes (1)
postoperative biliary reflux
3 months
Study Arms (1)
Single Anastomosis Sleeve Jejunal (SAS-J) Bypass
EXPERIMENTALSingle Anastomosis Sleeve Jejunal (SAS-J) Bypass as A treatment for Morbid
Interventions
Single Anastomosis Sleeve Jejunal (SAS-J) Bypass as A treatment for Morbid
Eligibility Criteria
You may qualify if:
- obese patients with BMI more than 40
- patients fit for laparoscopic surgery
- give approval to share in the study
You may not qualify if:
- patients refused to share in the study
- patients unfit for surgery
- patients aged less than 18 and older than 50
- patients with BMI less than 50
- patient with previous upper abdominal surgery either for obesity or other diseases
- patients with preoperative GERD clinically or by investigation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Minia Universitylead
Study Sites (1)
Minia university hospital
Minya, 61511, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Alaa M Sewefy, MD
Lecturer & consultant of general surgery, Department of surgery, Minia university hospital, Egypt.
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, Lecturer & consultant of general surgery, Department of surgery, Minia university hospital, Egypt
Study Record Dates
First Submitted
August 10, 2016
First Posted
August 17, 2016
Study Start
November 1, 2016
Primary Completion
April 1, 2017
Study Completion
April 1, 2017
Last Updated
March 11, 2022
Record last verified: 2022-02